ADVANTAGE 80 MG SPOT-ON SOLUTION FOR LARGE CATS AND LARGE PET RABBITS
Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Summary of Product characteristics
(SPC)
06-12-2016
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
IMIDACLOPRID
Available from:
Bayer Limited
ATC code:
QP53AX17
INN (International Name):
IMIDACLOPRID
Dosage:
80 Milligram
Pharmaceutical form:
Spot On Solution
Prescription type:
POM
Therapeutic group:
Feline, Rabbits
Therapeutic area:
Imidacloprid
Therapeutic indications:
Ectoparasiticide
Authorization status:
Authorised
Authorization date:
2012-02-24
Summary of Product characteristics
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Advantage 80 mg Spot-on solution for Large Cats and Large Pet Rabbits
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each 0.8 ml pipette contains:
ACTIVE SUBSTANCE:
Imidacloprid 80 mg
EXCIPIENT(S):
Butylhydroxytoluene (E 321)
0.8 mg
Benzyl alcohol
(E 1519)
665.6 mg
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Spot-on solution
Clear yellow to slightly brownish solution
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cats and pet rabbits
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For cats of 4 kg and greater:
Prevention and treatment of flea _(Ctenocephalides felis) _infestations.
For pet rabbits of 4 kg and greater:
Treatment of flea infestations.
Fleas are killed within one day following treatment. One treatment prevents further flea infestation for three to four
weeks on cats and up to one week on pet rabbits. The product can be used as part of a treatment strategy for the control
of Flea Allergy Dermatitis (FAD) in cats, where this has been previously diagnosed by a veterinary surgeon.
4.3 CONTRAINDICATIONS
Do not treat unweaned kittens of less than 8 weeks of age.
Do not use on pet rabbits of less than 10 weeks of age.
Do not use in case of hypersensitivity to the active substance or to any of the excipients.
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 21/11/2016_
_CRN 7023724_
_page number: 1_
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Re-infestation from emergence of new fleas in the environment may continue to occur for six weeks or longer after
treatment is initiated. More than one treatment may therefore be required, depending on the level of fleas
Read the complete document
